ABCB1 and neuroblastoma: YM155 also displayed synergistic action in neuroblastoma in in vitro and in vivo models in combination with lapatinib; the effect was attributed to lapatinib-induced inhibition of the ABCB1 efflux transporter, which allowed prolonged and elevated cytotoxicity of YM15543.